Cuvigny,T. et al., Bulletin de la Societe Chimique de France, 1973, p. 1174 - 1178
作者:Cuvigny,T. et al.
DOI:——
日期:——
Larcheveque,M. et al., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1975, vol. 280, p. 889 - 892
作者:Larcheveque,M. et al.
DOI:——
日期:——
Buys, Theo S. V.; Cerfontain, Hans; Geenevasen, Jan A. J., Recueil des Travaux Chimiques des Pays-Bas, 1990, vol. 109, # 10, p. 491 - 501
作者:Buys, Theo S. V.、Cerfontain, Hans、Geenevasen, Jan A. J.、Stunnenberg, Frank
DOI:——
日期:——
BUYS, THEO S. V.;CERFONTAIN, HANS;GEENEVASEN, JAN A. J.;STUNNENBERG, FRAN+, REC. TRAV. CHIM. PAYS-BAS., 109,(1990) N0, C. 491-501
作者:BUYS, THEO S. V.、CERFONTAIN, HANS、GEENEVASEN, JAN A. J.、STUNNENBERG, FRAN+
DOI:——
日期:——
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11SS-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
申请人:Masuda Koji
公开号:US20100240659A1
公开(公告)日:2010-09-23
Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor.
A compound represented by the formula:
, its pharmaceutically acceptable salt, or a solvate thereof,
wherein Ring A is a group represented by the formula:
Ring B is optionally substituted heteroaryl, provided that optionally substituted isoxazole is excluded, or optionally substituted heterocycle,
R
1
is hydrogen or optionally substituted alkyl,
R
2
is —OR
5
, —SR
5
, halogen, halogenated alkyl or the like,
R
3
is optionally substituted alkyl or the like,
R
4
is optionally substituted alkyl or the like,
R
5
is optionally substituted alkyl or the like,
R
6
is hydrogen or the like,
R
7
and R
8
are each independently hydrogen or the like,
R
10
and R
11
are each independently hydrogen or the like,
R
12
is optionally substituted alkyl or the like,
m and p are each independently integer of 1 to 3.